JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamacher, K. A.
Right arrow Articles by Sgouros, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamacher, K. A.
Right arrow Articles by Sgouros, G.

Cellular Dose Conversion Factors for {alpha}-Particle–Emitting Radionuclides of Interest in Radionuclide Therapy

Klaus A. Hamacher, Robert B. Den, Elana I. Den and George Sgouros

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York



View larger version (20K):

[in a new window]
  		FIGURE 1. Decay schemes for 225Ac, 211At, 213Bi, and 223Ra.

 


View larger version (56K):

[in a new window]
  		FIGURE 2. DCF values vs. {tau}0 for (C <- CS) where CS represents cell surface. Plots for several different cellular dimensions are shown and denoted by (RC, RN), representing radius of cell and of nucleus, respectively.

 


View larger version (52K):

[in a new window]
  		FIGURE 3. DCF values vs. {tau}0 for (N <- CS) where CS represents cell surface. Plots for several different cellular dimensions are shown and denoted by (RC, RN), representing radius of cell and of nucleus, respectively.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.